Clinical Trials
3 trialsNCT01199224 2017-11-21
To Determine the Food Effect and Bioavailability of Three Formulations of Veliparib in Subjects With Solid Tumors
AbbVie
Phase 1 Completed
NCT01472783 2016-11-16
Veli-BRCA
Vejle Hospital
Phase 1/2 Completed
NCT01193140 2012-11-21
To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors
Abbott
Phase 2 Completed